Identifying and repurposing antiviral drugs against severe acute respiratory syndrome coronavirus 2 with in silico and in vitro approaches-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identifying and repurposing antiviral drugs against severe acute respiratory syndrome coronavirus 2 with in silico and in vitro approaches

Published:2021-01 Issue: Volume:538 Page:137-144
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Watashi Koichi

Funder

Mochida Memorial Foundation for Medical and Pharmaceutical Research

Takeda Science Foundation

Smoking Research Foundation

Japan Science and Technology Agency

Japan Agency for Medical Research and Development

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference124 articles.

1. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China;Huang;Lancet,2020

2. A pneumonia outbreak associated with a new coronavirus of probable bat origin;Zhou;Nature,2020

3. A novel coronavirus from patients with pneumonia in China, 2019;Zhu;N. Engl. J. Med.,2020

4. The cost of new drug discovery and development;Dickson;Discov. Med.,2004

5. Druggable targets of SARS-CoV-2 and treatment opportunities for COVID-19;Faheem;Bioorg. Chem.,2020

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposed drugs for treatment against COVID-19;Everyman's Science;2023-05-17

2. Therapeutics for COVID-19;Nature Microbiology;2023-05-04

3. Novel Drug Design for Treatment of COVID-19: A Systematic Review of Preclinical Studies;Canadian Journal of Infectious Diseases and Medical Microbiology;2022-09-25

4. Dasabuvir Inhibits Human Norovirus Infection in Human Intestinal Enteroids;mSphere;2021-12-22

5. Case Study of High-Throughput Drug Screening and Remote Data Collection for SARS-CoV-2 Main Protease by Using Serial Femtosecond X-ray Crystallography;Crystals;2021-12-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3